SEARCH

    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    newshunt
    newshunt

    Trump's 100% tariffs on branded drugs: Indian generics spared but poses risks for pharma sector – Explained

    3 days ago

    US President Trump announced a 100% tariff on imported branded and patented pharmaceuticals starting October 2025, aiming to boost domestic manufacturing. Indian generic drug makers are largely unaffected initially, but concerns loom over potential tariff expansion to complex generics. Sun Pharma faces significant exposure due to its US branded portfolio.
    Click here to Read more
    Prev Article
    Bank holiday today: Are banks closed this weekend? Check state-wise list
    Next Article
    Mahesh Bhatt: Raha could replace Ranbir and Alia

    Related Business Updates:

    Comments (0)

      Leave a Comment